Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab
暂无分享,去创建一个
U. Ziemann | M. Krumbholz | B. Hemmer | C. Ruschil | M. Kowarik | C. Kemmerer | V. Pernpeintner | A. Abdelhak | M. Scholl | U. Ziemann | Christoph Ruschil | Verena Pernpeintner